Pelican-Cancer-Foundation-logos
Donate Now
Search
Pelican-Cancer-Foundation-logos

Dedicated to helping patients with bowel and liver cancer live well for longer

Donate Now
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • MERCURY 3
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

Dedicated to helping patients with bowel cancer live well for longer

Pelican Cancer Foundation is a medical research and education charity. We are the only charity in the UK dedicated solely to the research, training and advancement of precision surgery for bowel cancer and its associated secondary diseases, particularly in the liver.

2023-Symposium-group-photo-m

Bowel cancer is the 4th most common cancer in the UK and the 2nd biggest cancer killer. Every year nearly 43,000 people are diagnosed and sadly more than 16,500 people die of it. However, it can be treatable and curable if diagnosed early. Surgery often remains the most effective treatment for bowel cancer.

microscope

“In our view, all surgeons should come and see the experts work at Pelican. The bottom line is they’ll save lives as a result”

Professor Alex Deutsch, Chair of the Yanir Foundation for the Advancement of Colorectal Surgery, Israel

surgeons

Research

Pelican is pleased to announce that after the September 2024 research grant call, and review by the Research Review Panel a grant has been awarded to Prof Gina Brown and her team at Imperial College London to support MERCURY 3.

For patients with rectal cancer, planning treatment has been revolutionised by precision radiology. Pelican has helped develop, fund and deliver two world class research studies entitled MERCURY and MERCURY 2.  The original MERCURY studies changed the way pre-operative imaging for rectal cancer staging was carried out worldwide. This meant that with accurate MRI scans, many patients could be spared additional treatments before surgery by identifying those who could be cured with surgery alone.

MERCURY 3 will further refine the use of MRI to stage cancers in patients with rectal cancer.

 

 

More Info

Education

Each year Pelican delivers a series of education courses for healthcare clinicians from a range of disciplines including surgery, pathology, radiology, oncology and nursing.

These ground-breaking workshops and conferences cover the latest advances in cancer treatment, technology and surgical techniques and are run by an exceptional faculty of multi-disciplinary specialists.

  • Understanding and Managing Bowel Dysfunction after Rectal Cancer Surgery 30th April 2025
  • OReCO London 8th May 2025
  • Peritoneal Malignancy Wellbeing Day 5th June 2025
  • OReCO Dublin 2nd September 2025
  • OReCO Belfast 4th September 2025
  • KHP: Kent & Hampshire Hospitals NET 12th Meeting 3rd October 2025
  • OReCO Southwest 6th November 2025
  • OReCO West Midlands 21st January 2026

To hear more about the OReCO National Education Programme from Miss Amy Lord, Consultant Colorectal Surgeon and Pelican Research & Education Consultant: click here           

 

 

Book a course
milestone-films-white
patient-stories-white
fundraise
corporate-purple
gift-in-your-will
trusts

We receive no government funding and rely on the generosity of our donors to support our work

THANK YOU

foundrising_regulator
NIHR_logo
AMRC_logo
Ethical-MedTech-logosmall

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy